Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data
Background Psoriasis-related pruritus (PRP) in patients under systemic treatment is challenging. The risk to switch anti-psoriatic drugs and to lose response to previous therapy is high, thus dermatologists prefer to add an anti-pruritic agent. Objectives To evaluate the effect of anti-histamines an...
Main Authors: | Giovanni Damiani, Khalaf Kridin, Alessia Pacifico, Piergiorgio Malagoli, Paolo D. M. Pigatto, Renata Finelli, Fabio S. Taccone, Lorenzo Peluso, Rosalynn R. Z. Conic, Nicola L. Bragazzi, Young Dermatologists Italian Network, Marco Fiore |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-04-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2020.1840502 |
Similar Items
-
Review of therapeutic agents for burns pruritus and protocols for management in adult and paediatric patients using the GRADE classification
by: Ioannis Goutos, et al.
Published: (2010-09-01) -
Antihistamine therapy in pediatric practice
by: S. V. Tsarev
Published: (2018-07-01) -
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush
by: Nobuhiko Seki, et al.
Published: (2019-01-01) -
A case of severe paraneoplastic itch resistant to antihistamines and responding to serotonin reuptake inhibitors
by: Ines Werda, et al.
Published: (2021-07-01) -
Antihistamines in Pregnancy
by: Javad Ghaffari
Published: (2023-10-01)